Municipal Public Health Services once again conduct more STI consultations than before COVID-19 The number of STI consultations at the Sexual Health Centres of the Municipal Public Health Services (GGDs) was 19% higher in 2022 compared to 2021.
Provisional figures on participation in the National Immunisation Programme According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).
Vaccine manufacturer employee contracts poliovirus An employee of vaccine manufacturer Bilthoven Biologicals (BBio) has been infected with a poliovirus. The virus was found in a stool sample provided by the employee. The employee concerned is now in isolation.
Side effect reports National Immunisation Programme 2021 Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
BA.2.75 variant found in the Netherlands The BA.2.75 variant of the coronavirus SARS-CoV-2 has now also been found in the Netherlands. The variant was detected in a sample from 26 June 2022 taken in the region of Noordoost-Gelderland.
Participation in National Immunisation Programme shows slight decrease Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.
SARS-CoV-2 infections continue to rise Infections with the coronavirus SARS-CoV-2 in the Netherlands continued to rise this week. This increase can be seen in sewage surveillance and in the infections reported to the Municipal Public Health Services (GGDs).
Number of STI tests at sexual health centres are rising again In 2021, more than 138,000 people were tested for sexually transmitted infections (STIs) at a centre for sexual health.
Upward trend in infections continues Infections with the coronavirus SARS-CoV-2 in the Netherlands have increased for the third week in a row. The number of patients admitted to hospital nursing wards remained the same this week.
From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26 From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.